| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Fat emulsion (substance) |
Is a |
True |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fructose agent |
Is a |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amino acid injection |
Is a |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbohydrate agent |
Is a |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose [endocrine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 400 mg/g oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Parenteral glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fructose powder (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gamolenic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely gamolenic acid 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gamolenic acid 80 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gamolenic acid 80mg pediatric capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride+glucose 0.225%/5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sucrose 30% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 10% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 15% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 20% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 40% infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 50% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fructose 10% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride+glucose 0.18%/4% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride+glucose 0.18%/10% infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.45%/glucose 2.5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.45%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride+glucose 0.9%/5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 50% prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing carbohydrate (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Parenteral fructose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 70% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Essential fatty acid product (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Arginine hydrochloride 100mg/mL injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 60g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 25% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amino acids 10% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amino acid injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fructose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caloric agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing sucrose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cysteine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cholestyramine+aspartame 4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Stilbestrol+lactic acid 500micrograms/5% pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cysteine hydrochloride 50mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cysteine hydrochloride 50mg/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing lactic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing pectin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspartame-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing diethylstilbestrol and lactic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alpha-glucosidase-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5% in 0.2% Normal Saline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cholestyramine+aspartame |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.18%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 1000mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 60% in water intravenous solution 1000mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 150mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Infant dextrose 25% injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 500mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 60% in water intravenous solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 10mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 250mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amino acids 10% injection solution 500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 5g/100mL (5%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Urea+lactic acid 10/5% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid+lactic acid 16.7%/16.7% paint |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bupivacaine 0.5%+glucose injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing bupivacaine and glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 10% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 10% infusion solution 1 L polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 20% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 20% infusion solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 50% infusion solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 50% infusion solution 50 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 50% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 50% infusion solution 3 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 50% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 5% infusion solution 100 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 5% infusion solution 150 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 5% infusion solution 250 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Glucose 5% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.18%/glucose 4% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.18%/glucose 4% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.18%/glucose 4% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.9%/glucose 5% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.9%/glucose 5% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium chloride 0.9%/glucose 5% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gamolenic acid 20% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Evening primrose oil 20% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Iron sucrose 20mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing acesulfame potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 10% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 20% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextrose 30% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caloric agent (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]